Tg Therapeutics Inc (TGTX)

EBITDA Margin

16.79%

TTM · Period ending:

TGTX logo

TGTX EBITDA Margin

Latest reported16.79%
TGTX TTM EBITDA Margin (-933.33% → 16.79%)
High-resolution chart · PNG

TGTX ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Tg Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
16.7927%
21.4449%
21.8017%
21.6666%
21.5201%
18.2773%
15.2071%
2.2482%
31.3094%
18.6843%
11.1704%
-6.5352%
-682.7658%
-1,839.6453%
-6,739.5474%
-4,572.1194%
-4,024.9677%
-4,039.042%
-5,112.3785%
-7,640.9896%
-13,987.1997%
-34,340.0221%
-179,392.7632%
-147,010.5263%
-130,472.3684%
-120,305.9211%
-110,126.9737%
-120,999.3421%
-103,635.5263%
-109,561.8421%
-114,297.3684%
-99,030.8689%
-97,415.0902%
-87,033.6078%
-77,850.2569%
-72,880.6518%
-68,511.5546%
-60,375.7004%
-51,411.1812%
-47,600.082%
-40,052.2526%
-40,607.9432%
-41,011.3111%
-41,723.1925%
-44,370.2299%
-41,155.5076%
-36,377.8588%
-27,490.9411%
-18,878.9029%
-15,383.6679%
-12,838.6137%
-12,728.7166%
-15,894.898%
-14,891.4338%
-116,777.4937%
19,122.4567%
18,053.5009%
14,376.0221%
14,238.8497%
-311.6482%
-359.2834%
-397.876%
-421.5162%
-106.7218%
-0.1181%
-4.4953%
-26.3271%
-57.5934%
-139.127%
-156.8344%
-143.9088%
-200%
-300%
-462.5%
-68.75%
-78.125%
-122.2222%
-114.8148%
-1,866.6667%
-1,700%
-1,566.6667%
-1,600%
-1,233.3333%
-933.3333%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.